Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
Many patients with brain metastases from non-small cell lung cancer have limited survival, while others survive for several years, depending on patterns of spread, EGFR and ALK alterations, among others. The p...
Radiation Oncology 2017 12:107
Published on: 26 June 2017